Fundz

Dep Ymed reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEMay 04, 2023

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale Mar 27, 2023)

Round Type

Seed

FarmingdaleHealthcareHealth Care

Quick answer

DepYmed raised $2 Million in a Seed round, dated March 27, 2023. DepYmed is based in Farmingdale, New York, United States.

How much did DepYmed raise?
DepYmed raised $2 Million in a Seed round on March 27, 2023.
What does DepYmed do?
DepYmed is currently developing potent inhibitors of the enzyme PTP1B as therapeutics for cancer and rare diseases.
Where is DepYmed based and how big is it?
DepYmed is based in Farmingdale, New York, United States. Fundz records about 2 employees.
Who are the decision-makers at DepYmed?
Fundz holds 2 contacts at DepYmed. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as DepYmed that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $1.2M (Seed) on May 9, 2023.
  • Restor3D raised $12M on May 10, 2023.
  • Blueprint raised $6.6M on May 10, 2023.
  • Jaguar Health raised $1.8M (Seed) on May 8, 2023.
  • Jaguar Health raised $1.9M (Seed) on May 8, 2023.
  • Aware Recovery Care raised $25M on May 8, 2023.

Who to call at DepYmed, and when

A new round usually means DepYmed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DepYmed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DepYmed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DepYmed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DepYmed

Location

3 BIOSCIENCE PARK DRIVE

Farmingdale, New York, United States

About

DepYmed is currently developing potent inhibitors of the enzyme PTP1B as therapeutics for cancer and rare diseases. In addition, DepYmed has developed a portfolio of novel small molecules with copper chelating properties that can be applied as potential therapeutic agents for multiple diseases including Wilson Disease and cancer. ​

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DepYmed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts6 people are listed at DepYmed. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DepYmed's next move

See what Strategic adds

DepYmed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.